Catalyst Funds Management Pty »

Lineage Cell Therapeutics In shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-12-31 $104k 62k 1.67
2025-09-30 $106k 62k 1.69
2025-06-30 $75k 83k 0.91

More positions owned by Catalyst Funds Management Pty

Broadcom Ord Ordinary Shares (AVGO)
Rio Tinto Adr Rep One Ord Adr (RIO)
Apple Ord Ordinary Shares (AAPL)
Revolution Medicines Ord Ordinary Shares (RVMD)
Nvidia Ord Ordinary Shares (NVDA)
Walmart Ord Ordinary Shares (WMT)
Ftai Aviation Ord Ordinary Shares - Class A (FTAI)
Alphabet Cl C Ord Ordinary Shares - Class C (GOOG)
News Cl B Ord Ordinary Shares - Class B (NWS)
Reddit Cl A Ord Ordinary Shares - Class A (RDDT)
Albemarle Ord Ordinary Shares (ALB)
Jpmorgan Chase Ord Ordinary Shares (JPM)
Cheniere Energy Ord Ordinary Shares (LNG)
Curtiss Wright Ord Ordinary Shares (CW)
Lpl Financial Holdings Ord Ordinary Shares (LPLA)

View all positions for Catalyst Funds Management Pty

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Defender Capital
Raffles Associates
Brian McDonald
BlackRock
Millennium Management
Geode Capital Management
Renaissance Technologies
Goldman Sachs Group
Marshall Wace
State Street Corporation
Jane Street
Susquehanna International
Red Crane Wealth Management

View all funds holding Lineage Cell Therapeutics In